<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                           Array Escherichia Coli Clones Expressing Essential <br />                            Proteins: <br />                            New Strategy Identifying Cellular Targets Potent Antibacterial Compounds <br />  <br />                            Abstract <br />                                 advancement high throughput screening, easier faster discover hit <br />                                 compounds inhibit proliferation bacterial cells.  development technologies used <br />                                 identify cellular targets potent antibacterial inhibitors lagged                                  novel strategy target identification antibacterial inhibitors using array Escherichia coli <br />                                 clones expressing essential protein. proof concept study, essential <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 genes cloned pLex5BA vector control inducible promoter.  <br />                                 expression target proteins confirmed. clones, expressing FabI                                 expressing MurA enzymes, host cells 17-fold 139-fold resistant <br />                                 specific inhibitors triclosan phosphomycin, respectively, susceptibility                                 clones inhibitors remained unchanged induction gene expression. <br />                                 Target identification target protein expression demonstrated using mixed clone <br />                                 individual clone assay formats. <br />  <br />  <br />                            Keywords <br />                                 Escherichia coli; Essential genes; Drug targets; Antibacterial compounds; expression; <br />                                 Triclosan; Phosphomycin <br />  <br />  <br />                            Introduction <br />                                              past 20 years, emergence dissemination bacterial resistance existing <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              antibiotics increased alarming rate [1-3]. Especially troublesome emergence <br />                                              diverse pathogens multi-drug resistant [4-7], posing threat global <br />                                              public health. period, antibiotics New <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="chemical" datatype="xsd:string"></span>Chemical</span> Entities (NCEs) <br />                                              emerged [8], reflecting challenges identifying NCEs reduced <br />                                              commitment antibiotic drug discovery pharmaceutical companies. factor <br />                                              contributing dismal productivity therapeutic area lack                                              comprehensive knowledge bacterial essential genes. sequencing                                              complete microbial genome, Mycoplasma genitalium [9], decade ago, 350 <br />                                              bacterial genomes completely sequenced, including Escherichia coli [10], <br />                                              Bacillus subtilis [11] important human pathogens. rapid advances                                              microbial genomics potentially lead renewed efforts technological <br />  <br />  <br />                            *Corresponding author. Fax: +1 323 343 6451. E-mail address: hxu3@calstatela.edu (H. Howard Xu). <br />                            Publisher&apos;s Disclaimer: PDF file unedited manuscript accepted publication. service                            customers providing early version manuscript. manuscript undergo copyediting, typesetting, review                            resulting proof published final citable form. note production process errors                            discovered affect content, legal disclaimers apply journal pertain. <br />                             Xu et al.                                                                                                  Page 2 <br />  <br />  <br />                                            breakthroughs antibiotic drug discovery meet urgent medical need new <br />                                            antibiotics [12]. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Currently available antibiotics target approximately 20 estimated 200 essential gene <br />                                            products bacteria [13]. recognition utilities untapped potential antibiotic <br />                                            targets fostered various innovative approaches bacterial essential gene identification, <br />                                            facilitating development new discipline&#226;&#8364;&#8221;bacterial functional genomics. <br />                                            Comparative genomics combined conditional expression identify essential <br />                                            genes E. coli [14,15]. Promoter replacement techniques developed assess                                            essentiality Staphylococcus aureus genes [16,17]. Massive transposon mutagenesis                                            applied identify essential genes genome-scale M. genitalium [18], <br />                                            Haemophilus influenzae [19,20], E. coli [21]. Gene disruption methodologies                                            employed systematically identify essential genes Streptococcus pneumoniae [22]                                            B. subtilis [23]. Finally, regulated antisense expression [24,25] utilized identify                                            comprehensive set essential genes S. aureus. Conjoint analysis                                            computational models experimental strategies led proposition                                             standpoint cellular processes necessary maintain cellular life, minimal bacterial <br />                                            essential set contains 206 genes [13]. Bacterial essential genes far identified                                            increasingly used cell-based biochemical drug screens [26-28]. <br />  <br />                                            Historically, productive paradigm antibacterial lead discovery involved NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            straightforward initial screen inhibition bacterial growth. followed                                            laborious experimental attempts identify drug targets establish mechanisms action <br />                                            discovered antibacterial compounds. target hit compound <br />                                            identified, antibacterial potency selectivity optimized                                            synthesis testing structural analogs initial hit compound. increased <br />                                            exploitation chemical space  distance points approximates compound <br />                                            similarity), simple, fast straightforward identify inhibitors bacterial <br />                                            growth. remains difficult experimentally link inhibitor cellular target. <br />                                            need development fast comprehensive assay systems                                            identify cellular targets potent antibacterial inhibitors. Li colleagues [29] recently <br />                                            reported strategy identifying targets antibacterial inhibitors suppression                                            inhibition multicopy plasmid clones E. coli random genomic library.                                            approach does require large scale cloning efforts, difficult judge                                            comprehensiveness essential gene coverage clones genomic library <br />                                            detailed validation experiments. report, novel strategy                                            identify target inhibitor comprehensive collection (array) E. coli clones <br />                                            engineered express essential protein. strategy based concept <br />                                            elevated levels drug target protein confer resistance higher <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            concentrations specific inhibitor required bind excess target order                                            inhibit bacterial growth [30]. proof concept report, confirmed elevated <br />                                            inhibitor-specific resistance E. coli strains expressing specific essential targets                                            demonstrated identification cellular targets inhibitors using culture mixed <br />                                            clones parallel growth individual clones expressing particular essential <br />                                            gene. strategy applicable large number essential genes E. coli,                                            useful assay tool identify cellular targets inhibitors unknown <br />                                            mechanisms action. <br />  <br />                               Materials Methods <br />                               Bacterial strains, plasmid materials <br />                                            Purchased ATCC (Manassas, VA), E. coli K-12 strain MG1655 (Genotype: F- lambda- <br />                                            ilvG- rfb-50 rph-1) used source chromosomal DNA known genomic <br />  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                                Page 3 <br />  <br />  <br />                                            sequence [10] essential genes PCR amplified cloned. E. coli K-12 <br />                                            DH5&#206;&#177; obtained Invitrogen (Genotype: F-&#206;&#166;80&#206;&#8221;lacZ&#206;&#8221;M15 &#206;&#8221;(lacZYA-&#206;&#177;&#207;&#65533;&#206;&#179;F) U169 <br />                                            recA1 endA1 hsdR17 (rk-, mk+) phoA supE44 &#206;&#187;-thi-1 gyrA96 relA1). Expression vector <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            pLex5BA [31] used clone express essential genes control inducer <br />                                            isopropyl &#206;&#178;-D-thiogalactopyranoside (IPTG). Restriction enzymes T4 DNA ligase                                            purchased Invitrogen (Carlsbad, CA). Antibiotics inhibitors (ampicillin, <br />                                            phosphomycin triclosan), IPTG dithiothreitol (DTT) purchased Sigma- <br />                                            Aldrich (St. Louis, MO). Phenylmethylsulfonyl fluoride (PMSF) obtained Pierce <br />                                            (Rockford, . Difco Luria-Bertani (LB) broth powder purchased Fisher <br />                                            Scientific (Tustin, CA). E. coli cells grown LB broth agar media                                            appropriate antibiotic selection necessary (100 &#206;&#188;g/ml ampicillin). <br />  <br />                               Gene cloning <br />                                            E. coli essential genes PCR amplified using E. coli K-12 MG1655 genomic DNA                                            template cloned plasmid pLex5BA [31]. Essential genes selected                                            PEC (Profiling E. coli Chromosome) database. PCR primers designed include <br />                                            complete open reading frame (ORF) gene putative Shine-Delgarno <br />                                            sequence amplified product. Appropriate restriction endonuclease recognition sites <br />                                            designed PCR primers facilitate cloning process. Genes directionally <br />                                            cloned downstream IPTG-inducible promoter present plasmid [31]. <br />                                            Recombinant plasmid clones initially validated restriction digest agarose gel <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            electrophoresis. clone gene confirmed DNA sequencing using ABI <br />                                            Big-Dye terminator Kit 3.1 ABI 3100 Avant Genetic Analyzer (ABI, Foster City, <br />                                            CA). <br />  <br />                               expression cloned essential proteins E. coli <br />                                            Based procedure [32] modifications, cell-free protein extracts obtained <br />                                            E. coli cells various clones appropriate inducing conditions. Briefly, E. coli <br />                                            strain harboring plasmid inserted essential gene streaked LB agar plate <br />                                            100 &#206;&#188;g/ml ampicillin grown overnight 37 &#194;&#176;C. Erlenmeyer flask containing <br />                                            50 ml LB medium  100 &#206;&#188;g/ml ampicillin) inoculated 4 colonies                                            plate grown 37 &#194;&#176;C culture reached OD600 0.5. Expression                                            essential gene induced addition IPTG final concentration 1 mM                                            continued growth culture overnight (approximately 17 h) 37 &#194;&#176;C. 4 h                                            induction overnight induction milliliters culture harvested                                            resuspended 0.455 ml phosphate buffered saline (PBS: 137 mM NaCl; 2.7 mM KCl; 10 <br />                                            mM Na2HPO4; 2 mM KH2PO4). Lysozyme added final concentration 1 mg/ml <br />                                            suspension incubated ice 60 min. milliliter 0.2% Triton X-100 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            added, suspension vigorously mixed, DNase RNase enzymes                                            added final concentration 5 &#206;&#188;g/ml. mixture gently mixed 20 min 4 &#194;&#176;C <br />                                            rocking, followed centrifugation 3,500 &#195;&#8212; g 30 min 4 &#194;&#176;C. supernatant                                            collected placed fresh tube DTT PMSF added final <br />                                            concentration 1 mM. Glycerol final concentration 10%. cell-free <br />                                            protein extract stored -20 &#194;&#176;C subjected polyacrylamide gel electrophoresis <br />                                            analysis using precast protein gels Pierce (Rockford, . Following electrophoresis                                            protein gels stained Bio-Safe Coomassie blue Bio-Rad (Hercules, CA). <br />  <br />                               Determination inducer concentrations growth E. coli clones <br />                                            series IPTG dilutions combined, wells Corning Costar flat 96                                            microplate, LB broth plus ampicillin inoculated cells E. coli expression clones <br />                                             initial inoculation OD600 0.001). plate sealed clear thermal sealing <br />                                            film (E<span id='am-15' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-16' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span>amp</span>; K Scientific, Campbell, CA) growth 37&#194;&#176;C monitored <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                                    Page 4 <br />  <br />  <br />                                             kinetically Tecan Genios plate reader equipped incubation chamber (Tecan, <br />                                             Durham, NC). Plates read 30 min approximately 18 h low speed shaking <br />                                             prior read. E. coli cell growth curves optical density comparison charts NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             generated GraphPad Prizm software (San Diego, CA). <br />  <br />                               Drug dose response resistance testing <br />                                             Individual E. coli clones carrying plasmids containing essential genes grown LB <br />                                             medium 100 &#206;&#188;g/ml ampicillin maintenance plasmid, presence serial <br />                                             dilutions specific inhibitors available, inducer IPTG  final <br />                                             concentration 1 mM). growth experiments performed described using <br />                                             Corning Costar flat 96 microplates Tecan Genios plate reader. Inhibitor <br />                                             dose response curves generated GraphPad Prizm software. <br />  <br />                               Target identification using mixed clone assay format <br />                                             E. coli expressing clones mixed grown concentrations                                             triclosan phosphomycin levels inhibit parental strain inducing                                             noninducing conditions. Cells grown treatment conditions (8 &#206;&#188;g/ml triclosan 2 <br />                                             &#206;&#188;g/ml phosphomycin) presence 1 mM IPTG diluted plated selectable <br />                                             media obtain isolated colonies. Plasmid DNAs isolated restriction digest                                             performed determine identities insert DNAs. Sequence confirmation plasmid <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             inserts carried described  <br />  <br />                               Target identification using individual clone assay format <br />                                             test cellular targets antibacterial inhibitors identified using individually <br />                                             grown clones, expressing clones arrayed grown separate microplate rows <br />                                             various conditions. wells microplate contained triclosan (4 &#206;&#188;g/ml),                                             contained phosphomycin (2 &#206;&#188;g/ml). wells contained antibacterial inhibitors                                             serve innoculum control. Clones grown IPTG. Cell growth                                             microplate monitored Tecan Genios plate reader  <br />  <br />                               Results <br />                               Gene cloning <br />                                             PCR-amplified DNA fragments E. coli essential genes (Table 1) cloned                                             pLex5BA transformed E. coli DH5&#206;&#177; host cells. length identity insert <br />                                             DNA recombinant plasmids confirmed restriction digest analysis (Fig. 1)                                             DNA sequencing (data shown). essential genes chosen demonstrate <br />                                             proof concept strategy target identification target protein expression <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             encode variety essential target proteins involved distinct cellular <br />                                             functions pathways. MurA MurG enzymes involved bacterial <span id='am-27' about='obo:IMR_0001699' typeof='owl:Thing obo:IMR_0001790 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0000001 obo:IMR_0001700'><span id='am-28' property="oboInOwl:hasExactSynonym" content="murein" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasDbXref" content="KEGG:C00889" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:id" content="IMR:0001699" datatype="xsd:string"></span><span id='am-31' property="obo:IAO_0000115" content="Peptidoglycan (PGN) is a unique and essential component of the cell wall of virtually all bacteria, is not present in eukaryotes, and is an excellent target for the innate immune system." datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasDbXref" content="MeSH:D010457" datatype="xsd:string"></span><span id='am-33' property="rdfs:label" content="PGN" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasExactSynonym" content="PGN" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="peptidoglycan" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-37' property="rdfs:label" content="murein" datatype="xsd:string"></span>peptidoglycan</span> <br />                                             (cell wall) biosynthesis critical maintaining cellular integrity. FabD FabI                                             essential enzymes involved fatty acid biosynthesis. Tryptophanyl tRNA synthetase <br />                                             (TrpS), <span id='am-5' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-6' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span><span id='am-7' property="rdfs:label" content="peptide" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>peptide</span> chain release factor 2 (PrfB), 30S ribosomal protein S12 50S ribosomal <br />                                             protein L10 involved different facets protein synthesis. Conveniently, triclosan                                             phosphomycin known antibacterial inhibitors specific FabI MurA enzymes, <br />                                             respectively, available commercially test strategy. <br />  <br />                               Protein expression <br />                                             confirm expression cloned essential proteins, clones grown stationary <br />                                             phase induction initiated adding IPTG final concentration 1 mM. Cell <br />                                             culture samples taken 4 h 17 h (overnight) induction. Examples  <br />  <br />                                         Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                                Page 5 <br />  <br />  <br />                                            protein expression shown Figure 2. Results indicated FabI, MurA                                            TrpS clones, significant expression essential proteins 4 h induction <br />                                            continued induction 4 h did appear increase protein <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            expression. Specifically, protein bands similar intensity present 4 hr <br />                                            overnight post-induction samples MurA clone match calculated molecular <br />                                            weight (44.8 kD) MurA protein (Fig. 2). Similarly, cells TrpS clone produced                                            obviously expressed polypeptide band corresponds TrpS enzyme&#226;&#8364;&#8482;s calculated <br />                                            molecular weight (37.4kD) (Fig. 2). contrast, expression FabI clone resulted                                            protein band corresponding molecular weight 33 kDalton (Fig. 2),                                            inconsistent calculated molecular weight 28 kD. type discrepancies <br />                                            calculated molecular weight polypeptide electrophoretic outcome                                            unusual. Interestingly, Bergler coworkers expressed protein (FabI, used <br />                                            called EnvM) E. coli obtained similar result [33]. led believe <br />                                            observed exppressed protein FabI clone belonged FabI enzyme.                                            essential gene clones tested, PrfB clone demonstrated detectable  <br />                                            expression protein gel electrophoresis cell-free extracts (data shown). <br />  <br />                               Effects induction cell growth <br />                                            determine IPTG inducer expression essential <br />                                            proteins caused adverse effects growth clones  robust growth                                            clone critical target identification assays), individual clones grown NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            presence series IPTG concentrations 0.01 mM 10 mM. results <br />                                            indicated inducer concentrations high 10 mM  times high used                                            experiments) did cause significant growth defects TrpS, RplJ, FabI MurA clones <br />                                            (Fig. 3). Similar results obtained FabD, RpsL, PrfB, MurG vector clones (data <br />                                            shown) <br />  <br />                               Drug dose response resistance testing <br />                                            confirm concept target expression increases resistance specific inhibitors, <br />                                            FabI clone grown various concentrations triclosan  specific inhibitor                                            FabI enzyme) LB medium ampicillin presence absence 1 mM <br />                                            IPTG. Triclosan dose response curves FabI clone exhibited significant shift                                            presence inducer compared absence inducer (Fig. 4). IC50 <br />                                            values increased 584 ng/ml 9,927 ng/ml, 17-fold increase resistance,  <br />                                            expression FabI induced. contrast, expected vector contains insert, <br />                                            IC50 values vector clone did change (Fig. 4). MurA clone                                            grown various concentrations phosphomycin, specific inhibitor MurA <br />                                            enzyme, increase resistance dramatic  139-fold change IC50 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            values shown Fig. 5). Interestingly, elevated resistance conferred induction                                            target expression did require presence ampicillin medium (Fig. 6). <br />                                            ampicillin LB medium, cells MurA clone grew fairly presence <br />                                            8 &#206;&#188;g/ml phosphomycin condition induction (Fig. 6). absence                                            IPTG, cells failed grow 8 &#206;&#188;g/ml phosphomycin. Similar growth profiles                                            observed FabI clone absence ampicillin (data shown). <br />  <br />                                            determine increased resistance specific target inhibitor pairs <br />                                            involved, IC50 values obtained dose response curves E. coli clone treated <br />                                            triclosan phosphomycin presence absence inducer. ratio <br />                                            IC50 induced vs IC50 non-induced used measure changes clone&#226;&#8364;&#8482;s <br />                                            susceptibility particular inhibitor. Results indicated elevated resistance                                            triclosan observed FabI clone, seven  <br />                                            expression clones (Fig. 7). Similarly, elevated phosphomycin resistance evident  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                                 Page 6 <br />  <br />  <br />                                            MurA clone seven clones (Fig. 7). expression enzymes <br />                                            (FabD MurG) respective pathways did cause increases resistance                                            triclosan phosphomycin, respectively (Fig. 7). results indicate inhibitor <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            resistance result target protein expression highly specific. <br />  <br />                               Target identification using mixed clone assay <br />                                            specificity nature enhanced resistance target expression                                            scientific basis strategy identifying cellular targets using collection E. coli <br />                                            clones expressing particular target protein. expressing clones <br />                                            mixed subjected treatment inhibitory  parental strain) concentrations                                            triclosan phosphomycin, respectively, cell growth observed presence 1 <br />                                            mM IPTG treatments range inhibitor concentrations (data shown).                                            suspected cell growth observed enhanced resistance clone <br />                                            expressing specific target protein. test  cultures growth                                            wells containing 2 &#206;&#188;g/ml phosphomycin 8 &#206;&#188;g/ml triclosan serially diluted                                            plated LB agar plates 100 &#206;&#188;g/ml ampicillin. Isolated colonies                                            inhibitor treatment grown plasmids isolated perform restriction digest <br />                                            analysis. Restriction analysis results indicated 100% colonies phosphomycin <br />                                            treatment contained murA gene inserts 100% colonies triclosan treatment <br />                                            contained fabI gene inserts (Fig. 8a 8b). Subsequent plasmid DNA sequencing                                            confirmed growth result clones producing specific <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            target proteins specific inhibitors binds (data shown). <br />  <br />                               Target identification using individual clone assay <br />                                            test treatment inhibitor individually grown expression <br />                                            clones identify target inhibitor, expression clones                                            individually grown presence absence inhibitors triclosan (4 &#206;&#188;g/ml)                                            phosphomycin (2 &#206;&#188;g/ml), 1 mM IPTG (Fig. 9). seen Figure <br />                                            9, wells inhibitors, cells grew normally inducer                                            expected (used inoculum control). Microplate wells G5 G6, wells <br />                                            containing FabI clone triclosan IPTG present, produced robust growth <br />                                            similar wells inoculum control (Fig. 9). wells treated phosphomycin, <br />                                            wells (F1 F2) MurA clone row containing phosphomycin                                            inducer grew normally. <br />  <br />                               Discussion <br />                                            Recognition mechanism antibiotic resistance drug target expression <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            reported decades ago [34]. line research received little attention                                            years, probably earlier examples laboratory phenomena                                            clinical relevance [34,35]. recently,  reported target  <br />                                            expression probably accounts acquired resistance isoniazid ethambutol clinical <br />                                            isolates mycobacteria [36,37]. studies, expression targets                                            promoter mutations appeared responsible resistance drug resistant clinical <br />                                            isolates. laboratory setting, bacterial target proteins expressed                                            study function enzymes examine interaction inhibitors target <br />                                            proteins. expression prolipoprotein signal peptidase (gene product lsp)                                            shown confer host cells high level resistance globomycin, inhibitor                                            lipoprotein signal peptidase [38]. Turnowsky colleagues [39] demonstrated  <br />                                            expression EnvM (FabI) protein plasmid-borne gene conferred resistance                                            diazaborine, specific inhibitor FabI. Tsay coworkers [40] screened                                            thiolactomycin sensitive E. coli strain E. coli genomic library recombinant <br />  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                                  Page 7 <br />  <br />  <br />                                            plasmids conferred resistance thiolactomycin, inhibitor FabB protein (&#206;&#178;- <br />                                            ketoacyl-acyl carrier protein synthase . isolated plasmids, contain                                            functional fabB gene. expression FabB protein appeared lead increased <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            resistance thiolactomycin E. coli [40]. Apfel colleagues [41] demonstrated                                            expression peptide deformylase cell reduced susceptibility inhibitors <br />                                            specific essential target, peptide deformylase. <br />  <br />                                            Recently, reports using target expression confirm targets <br />                                            drugs inhibitors number microorganisms. expression farnesyl <br />                                            diphosphate synthase (FDP synthase) social amoeba Dictyostelium resulted resistance <br />                                            aminobisphosphate inhibitors [42]. Butcher coworkers [43] constructed pool                                            Saccharomyces cerevisiae strains expressing different protein. strains <br />                                            grown presence <span id='am-10' about='obo:IMR_0002818' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-11' property="oboInOwl:hasDbXref" content="KEGG:C07909" datatype="xsd:string"></span><span id='am-12' property="rdfs:label" content="rapamycin" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:id" content="IMR:0002818" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>rapamycin</span> growth monitored microarray. <br />                                            Candidate target proteins rapamycin identified [43]. approaches                                            groups [42,43] valuable robust, limited use identification                                            targets antifungal compounds. recent report using bacterial (E. coli), <br />                                            multicopy suppressors identified antibacterial compounds method                                            determining targets inhibitors mechanisms resistance [29]. study <br />                                            [29], E. coli random genomic library screened clones suppress <br />                                            antibacterial activities inhibitors hyperpermeable strain E. coli. result,                                            majority suppressors encode multidrug efflux pump AcrB target <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            lead compounds identified dihydrofolate reductase (DHFR), encoded                                            folA gene [29]. approach screening genomic libraries suppressor clones                                            significant method identifying targets antibacterial inhibitors.                                             random nature genomic libraries cloned inserts, difficult determine                                            essential gene structurally intact functionally expressed plasmid clone                                            extensive validation experiments. <br />  <br />                                            report deliberate effort clone individual essential genes E. coli                                            sole purpose constructing array E. coli expression clones identify <br />                                            cellular targets potent antibacterial inhibitors generated high throughput screening <br />                                            campaigns. proof concept, cloned essential genes E. coli, observed <br />                                            essential protein expression majority clones (seven                                             confirmed elevated resistance clones specific antibacterial inhibitors.                                            demonstrated proof concept identification targets known inhibitors.                                            results suggest approach likely generic provide viable tool <br />                                            identification cellular targets potent inhibitors studies drug-target <br />                                            interactions. Additionally, essential gene clone sequence validated  <br />                                            expression demonstrated, choices complimentary corroborating <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            assay formats identification targets potent inhibitors: mixed clone method <br />                                            individual clone method. assay formats advantages. mixed <br />                                            clone method streamlines number growth vessels (microplate wells) used                                            amplify slightest fitness advantages certain clones fitness test environment.                                            individually arrayed method advantageous positions clone                                            known advance, enables direct linkage growth particular target <br />                                            genetic profiling clones. addition, methods amenable robotic <br />                                            adaptation high throughput screening setting involving large number  <br />                                            expressing clones multiple potent antibacterial compounds. completed, array <br />                                            expression E. coli clones associated assays facilitate discovery                                            novel antibiotics. <br />  <br />  <br />  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />  <br />  <br />                                            Figure 1. <br />                                            Agarose gel stained ethidium bromide electrophoresis. Lane 1, DNA ladder; <br />                                            Lanes 2-10, various plasmids digested EcoR BamH  lane 2, vector pLex5BA; <br />                                            lane 3, pLex5BA-fabD; lane 4, pLex5BA-fabI; lane 5, pLex5BA-murA; lane 6, pLex5BA- <br />                                            murG; lane 7, pLex5BA-prfB; lane 8, pLex5BA-rplJ; lane 9, pLex5BA-rpsL; lane 10, <br />                                            pLex5BA-trpS. Note, restriction sites Shine-Delgarno sequences designed                                            PCR primers, sizes inserts shown gel slightly bigger ORF sizes <br />                                            listed Table 1. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                                Page 12 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Figure 2. <br />                                            Acrylamid gel electrophoresis separation protein extracts induction essential <br />                                            protein expression IPTG. Protein extracts cell cultures FabI clone (lanes 1-3), <br />                                            MurA clone (4-6) TrpS clone (7-9) adding inducer (1 mM IPTG) (lanes 1, 4, 7), <br />                                            4 h induction (lanes 2, 5, 8) 17 h induction (lanes 3, 6, 9). Lane 10, protein <br />                                            ladder. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                             Page 13 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Figure 3. <br />                                            Effect inducer concentrations growth E. coli clones (TrpS, RplJ, FabI                                            MurA). Cell growth wells microplate monitored kinetically using plate <br />                                            reader. concentration inducer clone, replicate wells used. <br />                                            Late log-phase (10 h) plate reading values used generate bar graph. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                              Page 14 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Figure 4. <br />                                            Increased resistance triclosan expression inhibitor-specific essential gene <br />                                            product, FabI. FabI clone grown presence serial dilutions triclosan                                            1 mM IPTG. vector control clone containing vector served                                            control. condition  respect inhibitor inducer), replicate wells                                            used. Late log-phase (10 h) plate read values used generate dose response graph. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                           Page 15 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Figure 5. <br />                                            Increased resistance phosphomycin expression inhibitor-specific essential <br />                                            gene product MurA. MurA clone grown presence serial dilutions                                            phosphomycin 1 mM IPTG. condition  respect inhibitor <br />                                            inducer), replicate wells used. Late log-phase (10 h) plate read values                                            used generate dose response graph. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                           Page 16 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Figure 6. <br />                                            Growth profiles cells MurA clone absence ampicillin. Cells grown                                            LB media ampicillin wells microplate presence absence IPTG <br />                                            phosphomycin. Growth monitored kinetically plate reader 37 &#194;&#176;C 17.5 <br />                                            h, optical density reading 0.5 h. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                             Page 17 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Figure 7. <br />                                            Specificity elevated resistance conferred target protein expression.                                            clones plus vector clone treated series concentrations                                            triclosan phosphomycin presence absence inducer (1 mM IPTG). Dose <br />                                            response curves clone plotted induced noninduced conditions. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            IC50 values obtained. ratio IC50 values (IC50 induced vs IC50 noninduced)                                            used measure fold increase resistance. <br />  <br />  <br />  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                              Page 18 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Figure 8. <br />                                            Restriction digest analysis isolated plasmids colonies obtained mixed strain <br />                                            treatment triclosan (4 &#206;&#188;g/ml)   phosphomycin (2 &#206;&#188;g/ml) (B).  fabI gene <br />                                            contains internal Pst site. EcoR Pst double digest pLex5BA  contains                                            Pst site polylinker) containing cloned fabI gene produce small fragments <br />                                            (620 231 bps) additional vector band. B, murA gene contains internal Hind <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            III site. EcoR Hind III double digest pLex5BA  contains Hind III site                                            polylinker) containing cloned murA gene produce fragments (841 465 bps)                                            addition vector band. <br />  <br />  <br />  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                             Page 19 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Figure 9. <br />                                            kinetic growth image microplate-based target identification assay. wells                                            row contained individual clone (marked right). Columns 1 4 contained 2 &#206;&#188;g/ml <br />                                            phosphomycin. Columns 5 8 contained 8 &#206;&#188;g/ml triclosan. Columns 9 12 contained <br />                                            inhibitor serve cell growth control. inhibitor treatment, half wells <br />                                            contained 1 mM IPTG half did (shown . <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                        Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />                             Xu et al.                                                                                                             Page 20 <br />  <br />  <br />  <br />  <br />                                                                                       Table 1 <br />                            E. coli essential genes cloned. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Gene   Gene Product (Target)                                                     Gene Size (base   E. coli Clone                                                                                                                   pairs) <br />  <br />                             fabD        Malonyl <span id='am-22' about='obo:IMR_0200354' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-23' property="rdfs:label" content="CoA" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:id" content="IMR:0200354" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasDbXref" content="KEGG:C00010" datatype="xsd:string"></span>CoA</span>-ACP transacylase                                              930               FabD clone <br />  <br />                             fabI        Enol-acyl carrier protein reductase                                       789               FabI clone <br />  <br />                             murA        <span id='am-38' about='obo:IMR_0200206' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-39' property="rdfs:label" content="UDP" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:id" content="IMR:0200206" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasDbXref" content="KEGG:C00015" datatype="xsd:string"></span>UDP</span>-N-acetylglucosamine enolpyruvyl transferase                           1260              MurA clone <br />  <br />                             murG        UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-   1068              MurG clone <br />                                         undecaprenol N-acetylglucosamine transferase <br />  <br />                             prfB        Peptide chain release factor 2                                            1023              PrfB clone <br />  <br />                             rplJ        50S ribosomal protein L10                                                 498               RplJ clone <br />  <br />                             rpsL        30S ribosomal protein S12                                                 375               RpsL clone <br />                             trpS        Tryptophanyl tRNA synthetase                                              1005              TrpS clone <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Biochem Biophys Res Commun. Author manuscript; available PMC 2011 September 19. <br />   <br /> </body></html>